Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.44059 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.31861 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.4171 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.31079 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.3007 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.49725 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.36453 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.32206 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.3208 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.34637 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.34355 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.37009 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.35282 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.35418 | 70 |